C
Amphastar Pharmaceuticals, Inc. AMPH
$29.79 -$0.715-2.34% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 31.03M 25.29M 37.96M 40.43M 37.95M
Total Depreciation and Amortization 16.24M 15.21M 14.66M 14.43M 14.15M
Total Amortization of Deferred Charges 842.00K 762.00K 724.00K 744.00K 2.44M
Total Other Non-Cash Items 6.01M 10.54M -15.74M 11.68M 5.94M
Change in Net Operating Assets -18.53M -16.71M -8.59M -7.33M 8.64M
Cash from Operations 35.59M 35.08M 29.02M 59.96M 69.11M
Capital Expenditure -10.57M -10.70M -12.41M -13.79M -6.04M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- 0.00 0.00 -129.00M
Divestitures -- -- -- -- --
Other Investing Activities 9.94M 21.18M -23.27M -20.79M 65.14M
Cash from Investing -625.00K 10.48M -35.68M -34.59M -69.90M
Total Debt Issued 4.13M 1.64M 4.87M 9.51M -25.00K
Total Debt Repaid -37.00K -38.00K -115.00K -41.00K -8.01M
Issuance of Common Stock 494.00K -- -- -- --
Repurchase of Common Stock -34.54M -15.69M -38.62M -31.70M -2.68M
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -253.00K -422.00K 22.00K -587.00K 1.00K
Cash from Financing -30.20M -14.50M -33.84M -22.82M -10.72M
Foreign Exchange rate Adjustments 142.00K 118.00K -11.00K -63.00K -19.00K
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 4.91M 31.17M -40.51M 2.50M -11.53M